Fennec Pharmaceuticals Inc (FENC)
9.085
-0.09
(-0.98%)
USD |
NASDAQ |
May 01, 16:00
9.085
0.00 (0.00%)
After-Hours: 17:30
Fennec Pharmaceuticals Debt to Equity Ratio: -2.661 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.661 |
| September 30, 2023 | -2.435 |
| June 30, 2023 | -2.610 |
| March 31, 2023 | -3.426 |
| December 31, 2022 | -9.692 |
| September 30, 2022 | 8.811 |
| June 30, 2022 | 0.5842 |
| March 31, 2022 | 0.3984 |
| December 31, 2021 | 0.3163 |
| September 30, 2021 | 0.2623 |
| June 30, 2021 | 0.2238 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-9.692
Minimum
Dec 2022
8.811
Maximum
Sep 2022
-0.5383
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
| Pfizer Inc | 0.7959 |
| OptiNose Inc | -1.504 |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 26.86M |
| Total Liabilities (Quarterly) | 38.49M |
| Shareholders Equity (Quarterly) | -11.62M |
| Current Ratio | 3.556 |
| Net Debt Paydown Yield | -0.41% |